Rhythm Biosciences LimitedASX: RHY

ColoSTAT Commercial Rollout Update

Aug 19, 2026 at 6:40 PM EDT · Issued by Rhythm Biosciences Limited via ASX

Filed with ASX · Aug 19, 2026 at 6:40 PM EDT

On 6ix: 6ix.com/news/colostat-commercial-rollout-update

ASX Announcement 20th August 2026 Revision: one Date Issued: 00/00/ Rhythm Biosciences Ltd ACN 619 459 335 ASX: RHY www.rhythmbio.com Australian Registered Address Bio21 Molecular Science & Biotechnology Institute 30 Flemington Road Parkville VIC 3010 Australia ...

View Attachment

6ix hasn’t read this filing yet.

Rhythm Biosciences Limited on 6ix

Earlier from Rhythm Biosciences

Bioshares 2026 PresentationAug 5
Quarterly Activities Report and Appendix 4CJul 29
Response to ASX Query LetterApr 14
First ColoSTAT Clinical Test SaleMar 10
NATA Accredits ColoSTAT Clinical Testing ServiceMar 8

Later from Rhythm Biosciences

Notification of cessation of securities - RHYAug 20
Appointment of Non-Executive DirectorsAug 25
FY26 Appendix 4E & Audited Financial ReportAug 27
Initial Director's Interest Notice - Maureen BakerAug 28
Initial Director's Interest Notice - Carl StubbingsAug 28

All Rhythm Biosciences news releases

Follow Rhythm Biosciences into a list and get an email when it puts out news.

Follow Rhythm Biosciences